Structural Insight into the Critical Role of the N-Terminal Region in the Catalytic Activity of Dual-Specificity Phosphatase 26

PLoS One. 2016 Sep 1;11(9):e0162115. doi: 10.1371/journal.pone.0162115. eCollection 2016.

Abstract

Human dual-specificity phosphatase 26 (DUSP26) is a novel target for anticancer therapy because its dephosphorylation of the p53 tumor suppressor regulates the apoptosis of cancer cells. DUSP26 inhibition results in neuroblastoma cell cytotoxicity through p53-mediated apoptosis. Despite the previous structural studies of DUSP26 catalytic domain (residues 61-211, DUSP26-C), the high-resolution structure of its catalytically active form has not been resolved. In this study, we determined the crystal structure of a catalytically active form of DUSP26 (residues 39-211, DUSP26-N) with an additional N-terminal region at 2.0 Å resolution. Unlike the C-terminal domain-swapped dimeric structure of DUSP26-C, the DUSP26-N (C152S) monomer adopts a fold-back conformation of the C-terminal α8-helix and has an additional α1-helix in the N-terminal region. Consistent with the canonically active conformation of its protein tyrosine phosphate-binding loop (PTP loop) observed in the structure, the phosphatase assay results demonstrated that DUSP26-N has significantly higher catalytic activity than DUSP26-C. Furthermore, size exclusion chromatography-multiangle laser scattering (SEC-MALS) measurements showed that DUSP26-N (C152S) exists as a monomer in solution. Notably, the crystal structure of DUSP26-N (C152S) revealed that the N-terminal region of DUSP26-N (C152S) serves a scaffolding role by positioning the surrounding α7-α8 loop for interaction with the PTP-loop through formation of an extensive hydrogen bond network, which seems to be critical in making the PTP-loop conformation competent for phosphatase activity. Our study provides the first high-resolution structure of a catalytically active form of DUSP26, which will contribute to the structure-based rational design of novel DUSP26-targeting anticancer therapeutics.

MeSH terms

  • Amino Acid Sequence
  • Catalysis
  • Catalytic Domain
  • Cell Line, Tumor
  • Chromatography, Gel
  • Crystallography, X-Ray
  • Dual-Specificity Phosphatases / chemistry
  • Dual-Specificity Phosphatases / metabolism*
  • Humans
  • Mitogen-Activated Protein Kinase Phosphatases / chemistry
  • Mitogen-Activated Protein Kinase Phosphatases / metabolism*
  • Protein Conformation
  • Sequence Homology, Amino Acid

Substances

  • Mitogen-Activated Protein Kinase Phosphatases
  • DUSP26 protein, human
  • Dual-Specificity Phosphatases

Grants and funding

This work was supported by the National Research Foundation of Korea(NRF) grants funded by the Korea government(MEST) (2011-0030027; to SJK, NRF-2012M3C1A3671508 and NRF-2014R1A2A2A05002961; to SWC) and by the Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation (NRF-2015M3A9C4076320; to SWC). This work was also supported by the KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.